Allurion Technologies Inc (ALUR)

$1.23 -0.03 (-2.38%)
Market Cap 11.67M
Revenue (ttm) 32.11M
Net Income (ttm) -26.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -81.44%
Debt to Equity Ratio 0.00
Volume 73,600
Avg Vol 230,398
Day's Range N/A - N/A
Shares Out 9.26M
Stochastic %K 14%
Beta -0.45
Analysts Sell
Price Target $5.25

Company Profile

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Tur...

Industry: Medical Devices
Sector: Healthcare
Phone: 508 647 4000
Address:
11 Huron Drive, Natick, United States
Ray89c
Ray89c Dec. 30 at 11:48 AM
$ALUR something needs to cook up soon as weight loss market heating up with $NVO $LLY pricing down in India and China. FDA approval in US followed by test result from GLP combination this has lots of room to run. Let’s hope for the best.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 29 at 4:46 PM
$ALUR RSI: 17.35, MACD: -0.0687 Vol: 0.13, MA20: 1.53, MA50: 1.60 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Dizzier47
Dizzier47 Dec. 29 at 12:28 PM
$ALUR shantanu has abandoned us
0 · Reply
Ray89c
Ray89c Dec. 24 at 2:50 PM
$ALUR man we need more attention here. With 800 bucks volume it moved 7% . Group of buyer can hit this through the roof. $TLRY $BYND $NFE $VELO army load up on this one. FDA approval 3 months away.
3 · Reply
Sjpu
Sjpu Dec. 23 at 3:05 AM
$ALUR Shantanu probably not too happy with $NVO 💊. Lets see if ballooned is popped even before it could do anything
2 · Reply
Dizzier47
Dizzier47 Dec. 22 at 7:15 PM
$ALUR lord shantanu should do a purchase then
0 · Reply
Ray89c
Ray89c Dec. 22 at 6:39 PM
$ALUR not sure what’s pulling this down. Such a low float one sell dumps one buy pumps lol . Let’s hold till March . We get fat cheque
0 · Reply
Dizzier47
Dizzier47 Dec. 22 at 2:57 PM
$ALUR this fat garbage is the heaviest thing in my portfolio but i trust it will pull through
0 · Reply
ThatDudeWithNoMoney
ThatDudeWithNoMoney Dec. 20 at 12:57 AM
Next 2 weeks should get interesting for $ALUR & $XAIR $AZI $MIMI
1 · Reply
JohnTrack
JohnTrack Dec. 19 at 10:24 PM
$ALUR Another future split? it cant be real... https://www.rapidticker.com/news/alur-sec-filing-3964e6
0 · Reply
Latest News on ALUR
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

Nov 25, 2025, 9:25 AM EST - 5 weeks ago

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone

Nov 20, 2025, 9:00 AM EST - 5 weeks ago

New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone

Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss

Nov 18, 2025, 9:00 AM EST - 6 weeks ago

Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss

Allurion Technologies Inc. (ALUR) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 10:21 AM EST - 7 weeks ago

Allurion Technologies Inc. (ALUR) Q3 2025 Earnings Call Transcript

Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 12, 2025, 8:00 AM EST - 7 weeks ago

Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update

Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing

Nov 11, 2025, 8:45 AM EST - 7 weeks ago

Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing

Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025

Nov 6, 2025, 4:05 PM EST - 7 weeks ago

Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025

Allurion Announces Landmark Peer-Reviewed Publication on Consecutive Use of the Allurion Smart Capsule Showing More Than 20% Weight Loss

Oct 7, 2025, 8:00 AM EDT - 3 months ago

Allurion Announces Landmark Peer-Reviewed Publication on Consecutive Use of the Allurion Smart Capsule Showing More Than 20% Weight Loss

Allurion to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Sep 30, 2025, 4:05 PM EDT - 3 months ago

Allurion to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Allurion Technologies Inc. (ALUR) Q2 2025 Earnings Call Transcript

Aug 13, 2025, 12:14 PM EDT - 5 months ago

Allurion Technologies Inc. (ALUR) Q2 2025 Earnings Call Transcript

Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 13, 2025, 8:00 AM EDT - 5 months ago

Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update

Allurion to Report Second Quarter 2025 Financial Results on August 13, 2025

Aug 7, 2025, 4:05 PM EDT - 5 months ago

Allurion to Report Second Quarter 2025 Financial Results on August 13, 2025

Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry

Aug 5, 2025, 8:00 AM EDT - 5 months ago

Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry

Allurion Announces New Publications on Long-Term Weight Loss Results with the Allurion Program

Jul 22, 2025, 8:00 AM EDT - 5 months ago

Allurion Announces New Publications on Long-Term Weight Loss Results with the Allurion Program

Allurion Announces Strategic Distribution Partnership with Minogue Medical in Canada to Pioneer New Approach Focused on Metabolically Healthy Weight Loss

Jul 9, 2025, 4:05 PM EDT - 6 months ago

Allurion Announces Strategic Distribution Partnership with Minogue Medical in Canada to Pioneer New Approach Focused on Metabolically Healthy Weight Loss

Allurion Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study That Meet Both Endpoints

Jul 7, 2025, 8:00 AM EDT - 6 months ago

Allurion Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study That Meet Both Endpoints

Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS

Jun 17, 2025, 8:00 AM EDT - 7 months ago

Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS

Allurion to Present at Jefferies Global Healthcare Conference

May 29, 2025, 4:05 PM EDT - 7 months ago

Allurion to Present at Jefferies Global Healthcare Conference

Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program

May 27, 2025, 4:05 PM EDT - 7 months ago

Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program

Allurion Technologies Inc. (ALUR) Q1 2025 Earnings Call Transcript

May 14, 2025, 2:44 PM EDT - 8 months ago

Allurion Technologies Inc. (ALUR) Q1 2025 Earnings Call Transcript

Allurion Reports First Quarter 2025 Financial Results and Provides Business Update

May 14, 2025, 8:00 AM EDT - 8 months ago

Allurion Reports First Quarter 2025 Financial Results and Provides Business Update

Allurion Presents Data on the Allurion Balloon and AI-Powered Virtual Care Suite with and without GLP-1s to Optimize Muscle Mass and Increase Weight Loss

May 13, 2025, 4:05 PM EDT - 8 months ago

Allurion Presents Data on the Allurion Balloon and AI-Powered Virtual Care Suite with and without GLP-1s to Optimize Muscle Mass and Increase Weight Loss

Allurion to Report First Quarter 2025 Financial Results on May 14, 2025

May 5, 2025, 4:05 PM EDT - 8 months ago

Allurion to Report First Quarter 2025 Financial Results on May 14, 2025

Allurion Announces Postponement of Special Meeting of Stockholders

Apr 3, 2025, 4:30 PM EDT - 9 months ago

Allurion Announces Postponement of Special Meeting of Stockholders

Allurion Technologies Inc. (ALUR) Q4 2024 Earnings Call Transcript

Mar 26, 2025, 10:44 AM EDT - 10 months ago

Allurion Technologies Inc. (ALUR) Q4 2024 Earnings Call Transcript

Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Mar 26, 2025, 8:00 AM EDT - 10 months ago

Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Mar 20, 2025, 4:05 PM EDT - 10 months ago

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025

Mar 12, 2025, 4:05 PM EDT - 10 months ago

Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity

Mar 4, 2025, 4:05 PM EST - 10 months ago

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity

Allurion to Participate in Upcoming Investor Conferences

Feb 25, 2025, 4:05 PM EST - 11 months ago

Allurion to Participate in Upcoming Investor Conferences

Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Feb 20, 2025, 4:05 PM EST - 11 months ago

Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Feb 19, 2025, 9:03 AM EST - 11 months ago

Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity

Feb 18, 2025, 8:30 AM EST - 11 months ago

Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity

Allurion Relaunches in France

Feb 13, 2025, 8:30 AM EST - 11 months ago

Allurion Relaunches in France

Allurion Technologies Shares Are Up Today: What's Going On?

Jan 24, 2025, 1:25 PM EST - 1 year ago

Allurion Technologies Shares Are Up Today: What's Going On?

Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs

Jan 24, 2025, 11:50 AM EST - 1 year ago

Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs

Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market

Jan 24, 2025, 9:30 AM EST - 1 year ago

Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market

Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program

Jan 23, 2025, 3:48 PM EST - 1 year ago

Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program

Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity

Jan 21, 2025, 8:30 AM EST - 1 year ago

Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

Jan 14, 2025, 9:18 AM EST - 1 year ago

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

Allurion Announces Positive Topline Results From AUDACITY Trial

Jan 8, 2025, 8:00 AM EST - 1 year ago

Allurion Announces Positive Topline Results From AUDACITY Trial

Allurion Technologies, Inc. Announces Reverse Stock Split

Dec 24, 2024, 7:00 AM EST - 1 year ago

Allurion Technologies, Inc. Announces Reverse Stock Split

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance

Dec 2, 2024, 8:00 AM EST - 1 year ago

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance

Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program

Nov 25, 2024, 8:00 AM EST - 1 year ago

Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program

Allurion Technologies Inc. (ALUR) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 12:43 PM EST - 1 year ago

Allurion Technologies Inc. (ALUR) Q3 2024 Earnings Call Transcript

Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 13, 2024, 8:00 AM EST - 1 year ago

Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update

Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society's Annual Conference

Nov 4, 2024, 8:10 AM EST - 1 year ago

Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society's Annual Conference

Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024

Oct 30, 2024, 8:30 AM EDT - 1 year ago

Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024

Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon

Oct 23, 2024, 8:00 AM EDT - 1 year ago

Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon

October's 4 Best Penny Stocks: High-Risk, High-Reward Picks

Oct 9, 2024, 1:46 PM EDT - 1 year ago

October's 4 Best Penny Stocks: High-Risk, High-Reward Picks

GEVO KULR LUCD

Ray89c
Ray89c Dec. 30 at 11:48 AM
$ALUR something needs to cook up soon as weight loss market heating up with $NVO $LLY pricing down in India and China. FDA approval in US followed by test result from GLP combination this has lots of room to run. Let’s hope for the best.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 29 at 4:46 PM
$ALUR RSI: 17.35, MACD: -0.0687 Vol: 0.13, MA20: 1.53, MA50: 1.60 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Dizzier47
Dizzier47 Dec. 29 at 12:28 PM
$ALUR shantanu has abandoned us
0 · Reply
Ray89c
Ray89c Dec. 24 at 2:50 PM
$ALUR man we need more attention here. With 800 bucks volume it moved 7% . Group of buyer can hit this through the roof. $TLRY $BYND $NFE $VELO army load up on this one. FDA approval 3 months away.
3 · Reply
Sjpu
Sjpu Dec. 23 at 3:05 AM
$ALUR Shantanu probably not too happy with $NVO 💊. Lets see if ballooned is popped even before it could do anything
2 · Reply
Dizzier47
Dizzier47 Dec. 22 at 7:15 PM
$ALUR lord shantanu should do a purchase then
0 · Reply
Ray89c
Ray89c Dec. 22 at 6:39 PM
$ALUR not sure what’s pulling this down. Such a low float one sell dumps one buy pumps lol . Let’s hold till March . We get fat cheque
0 · Reply
Dizzier47
Dizzier47 Dec. 22 at 2:57 PM
$ALUR this fat garbage is the heaviest thing in my portfolio but i trust it will pull through
0 · Reply
ThatDudeWithNoMoney
ThatDudeWithNoMoney Dec. 20 at 12:57 AM
Next 2 weeks should get interesting for $ALUR & $XAIR $AZI $MIMI
1 · Reply
JohnTrack
JohnTrack Dec. 19 at 10:24 PM
$ALUR Another future split? it cant be real... https://www.rapidticker.com/news/alur-sec-filing-3964e6
0 · Reply
Ray89c
Ray89c Dec. 18 at 11:25 PM
$TNYA I am holding this & $ALUR till the FDA approval . Easy 5x. Be patient till March
0 · Reply
Dizzier47
Dizzier47 Dec. 16 at 11:19 PM
$ALUR every day we get closer to shantanu
0 · Reply
Ray89c
Ray89c Dec. 15 at 9:15 AM
I can sense that I might be closing big before new years. Got 9k shares of $TNYA at .83 , Holding $KULR 8k shares $TLRY 7k shares $ALUR 40k shares $NMG 3k shares
0 · Reply
Dizzier47
Dizzier47 Dec. 12 at 6:50 PM
$ALUR do it shantanu go full power
0 · Reply
ChaseDeluca
ChaseDeluca Dec. 12 at 3:03 PM
$ALUR $KULR $TLRY $VELO watch IMCC Cannabis stocks are starting to wake up again, and IMCC is one of the few still sitting at the absolute bottom with no dilution, a clean multi-month base, and valuation models far above the current market cap. Every major cannabis rally has had that one sleeper that stayed quiet right before the whole sector ignited IMCC has that exact energy right now.
0 · Reply
Ray89c
Ray89c Dec. 12 at 2:56 PM
$VELO time to move to $TLRY $KULR $ALUR
0 · Reply
Ray89c
Ray89c Dec. 12 at 2:21 PM
$TLRY all the wait was worth it . Let’s kill it $TLRY & $ALUR
0 · Reply
mrsam26
mrsam26 Dec. 11 at 10:00 PM
$ALUR does $LLY 's retatrutide kill alur? Great data posted today and may take a majority of $ALUR moat.
1 · Reply
Dizzier47
Dizzier47 Dec. 9 at 12:27 PM
$ALUR cashier handed me a bag with balloons on it. sign from above. this is mooning
0 · Reply
Ray89c
Ray89c Dec. 4 at 6:07 PM
$KULR very happy with this and $ALUR both getting lambos soon
0 · Reply
Ray89c
Ray89c Dec. 4 at 5:13 PM
$ALUR once the FDA approval comes this goes to $20 in a flash. Only 2mn traceable shares. 8mn float
0 · Reply
Dizzier47
Dizzier47 Dec. 4 at 5:07 PM
$ALUR I'm Shantanuing it up
0 · Reply